Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
| NCT02548286 | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs | ||
| NCT01162005 | Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children | ||
| NCT01842256 | Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. | ||
| NCT02586311 | CKD-330 Phase 3 Trial in Amlodipine Non-responder | ||
| NCT03017950 | Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT05540912 | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects | ||
| NCT07577518 | Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome | ||
| NCT02044250 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | ||
| NCT06758661 | Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers | ||
| NCT01128322 | CKD-828 Primary Hypertension Trial(Dose-selection) | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT02977065 | To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors | ||
| NCT04260438 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects | ||
| NCT03414840 | Assessment of Change in Atherosclerotic Plaque by Serial CCTA | ||
| NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
| NCT02615782 | A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects | ||
| NCT01580371 | Safety and Pharmacokinetic Profile of CKD-581 | ||
| NCT02206165 | A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension | ||
| NCT04224350 | Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) | ||
| NCT03849261 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | ||
| NCT04246190 | A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396 | ||
| NCT03713892 | CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects | ||
| NCT04069065 | Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) | ||
| NCT02894541 | Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT01746680 | Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis | ||
| NCT04628143 | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT04102943 | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. | ||
| NCT04673682 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 | ||
| NCT06954766 | Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 | ||
| NCT07304700 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT02300467 | NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors | ||
| NCT04488900 | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects | ||
| NCT02047175 | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) | ||
| NCT02007941 | Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects | ||
| NCT03583905 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet | ||
| NCT04706286 | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 | ||
| NCT04035538 | A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012 | ||
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT02981212 | Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy | ||
| NCT06386328 | A Clinical Trial to Evaluate the Food Effect of CKD-378 | ||
| NCT04258865 | A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 | ||
| NCT03233932 | CKD-841 Pharmacokinetic/Pharmacodynamic Study | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT05657574 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia | ||
| NCT01030679 | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus | ||
| NCT05843162 | A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome | ||
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | ||
| NCT04611932 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers |
